Skip to main content
. 2022 Oct 21;22:1274. doi: 10.1186/s12913-022-08697-6

Table 1.

Baseline characteristics of the low-risk group at the primary care emergency clinic

OUT-ACS
total
n = 1711
(100%)
Not admitted to hospital
n = 1485
(86.8%)
Admitted to hospital
n = 226
(13.2%)
Male sex, n (%) 895 (52.3) 764 (51.4) 131 (58.0)
Age, median (IQR) 56 (45–68) 55 (44–66) 63.5 (51–73)
Risk factors for CVD, n (%)
 Current/history of smoking 449 (26.2) 387 (26.1) 62 (27.4)
 Previous coronary artery disease 317 (18.5) 262 (17.6) 55 (24.3)
 Hypertension 448 (26.2) 379 (25.5) 69 (30.5)
 Dyslipidaemia 422 (24.7) 369 (24.8) 53 (23.5)
 Other CVDa 288 (16.8) 228 (15.4) 60 (26.5)
 Diabetes mellitus 171 (10.0) 143 (9.6) 28 (12.4)
 COPD 80 (4.7) 58 (3.9) 22 (9.7)
 Family history of CVD 691 (40.4) 603 (40.6) 87 (38.5)
Presenting acute symptoms (%)
 Chest pain 1486 (86.8) 1301 (87.6) 184 (81.4)
  Constricting 1239 (72.4) 1082 (72.9) 157 (69.5)
  Sharp 404 (23.6) 358 (24.1) 46 (20.4)
  Tearing 64 (3.7) 58 (3.9) 6 (2.7)
  Burning 208 (12.2) 183 (12.3) 25 (11.1)
  Respiratory dependent 302 (17.7) 251 (16.9) 51 (22.6)
  Chest wall tenderness 205 (12.0) 184 (12.4) 21 (9.3)
  Movement dependent 219 (12.8) 197 (13.3) 21 (9.3)
 Other pain (abdomen, back, neck) 48 (2.8) 39 (2.6) 9 (4.0)
 No pain 177 (10.3) 144 (9.7) 33 (14.6)
 Pain radiation 972 (56.8) 865 (58.2) 135 (59.7)
 Dyspnea 901 (52.7) 768 (51.7) 133 (58.8)
 Palpitations 637 (37.2) 558 (37.6) 79 (35.0)
 Syncope/pre-syncope 460 (26.9) 391 (26.3) 69 (30.5)
 Acute fatigue 571 (33.4) 488 (32.9) 83 (36.7)
 Nausea and/or vomiting 732 (42.8) 641 (43.2) 91 (40.3)
 Diaphoresis 561 (32.8) 490 (33.0) 71 (31.4)
First ECG, n (%)
 Normal 1515 (88.5) 1332 (89.7) 183 (81.0)
 Non-specific changesb 196 (11.5) 153 (10.3) 43 (19.0)
Symptom onset to first hs-cTnT, n (%)
  < 3 h 182 (10.6) 161 (10.8) 21 (9.3)
 3 – 5.99 h 609 (35.6) 532 (35.8) 77 (34.1)
 6 – 11.99 h 409 (23.9) 336 (22.6) 73 (32.3)
  > 12 h 511 (29.9) 456 (30.7) 55 (24.3)
According to the 0/1-h algorithm
 Rule-out (0/1 h) 1311 (76.6) 1232 (83.0) 79 (35.0)
 Observation group (0/1 h) 334 (20.5) 243 (16.4) 91 (40.3)
 Rule-in (0/1 h) 66 (3.9) 10 (0.7) 56 (24.8)
HEART risk score
 Low risk (0–3 points) 871 (50.9) 805 (54.2) 66 (29.2)
 Intermediate risk (4–6 points) 760 (44.4) 633 (42.6) 127 (56.2)
 High risk (7–10 points) 80 (4.7) 47 (3.2) 33 (14.6)
Endpoints
 Myocardial infarctions at index 61 (3.6) 1 (0.1) 60 (26.5)
 Myocardial infarctions after 30 days 3 (0.2) 3 (0.2) 0 (0.0)
 Myocardial infarctions after 90 days 2 (0.1) 1 (0.1) 1 (0.4)
 Deaths after 30 days 5 (0.3) 1 (0.1) 4 (1.8)
 Deaths after 90 days 4 (0.2) 1 (0.1) 3 (1.3)

All values are presented as n (%) or median (IQR). As the low-risk hospital cohort was obtained from administrative data only, we do not have additional baseline characteristics for these patients. However, for the purpose of this analysis, we consider the non-hospitalised OUT-ACS cohort comparable to the low-risk patients at Drammen hospital

COPD Chronic obstructive pulmonary disease, CVD Cardiovascular disease, ECG Electrocardiogram, hs-cTnT High-sensitivity cardiac troponin T, IQR Interquartile range; One hoUr Troponin in a low-prevalence of Acute Coronary Syndrome

aIncludes atrial fibrillation, other arrhythmias, cardiomyopathies, cerebral stroke, heart failure, or valvular disease

bNon-specific changes in either the ST-segment, T-inversions, Q-waves, atrial fibrillation, pacemaker or left/right bundle branch block of unknown clinical significance